SURVEY OF BONE DENSITY BY ABSORBING DUAL ENERGY X -RAYS AND SOME FACTORS THE RISK OF OSTEOPOROSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE HAS NOT BEEN TREATED FOR KIDNEY REPLACEMENT AT THAI BINH GENERAL HOSPITAL

Thủy Trần Xuân, Hùng Vũ Phi, Anh Bùi Thị Lan

Main Article Content

Abstract

Objectives: Survey of bone density by absorbing dual energy X -rays and some factors The risk of osteoporosis in patients with chronic kidney disease has not been treated for kidney replacement at Thai Binh General Hospital. Subjects and methods: The study described cross -sectional conducted on 84 patients with chronic kidney disease has not been treated for kidney replacement at the Department of Nephrology- Musculoskeletal Osteoarthritis Hospital of Thai Binh Province. Results: The average age research object is 66 ± 12.7 years old. 65.5% of patients increase the concentration of PTH hormones. According to the results of bone density measurement at the average value of BMD/T-SCORE/Z-SCORE, 1.13/0.01/1.5. According to the results of bone density measurement at CXD, the average value of BMD/T-SCORE/Z-SCORE is 0.82/-0.44/0.98, respectively. The rate of osteoporosis increases in age group, from 0% in patients 40-50 years old to 63.2% in patients over 70 years old. The ratio of osteoporosis tends to increase in the period of BTM, from 10.5% in phase II to 31.6% at the stage of V. The rate of reducing bone density ranges from 6.2% to 28.1%. There are 57.9% of people with glomerular filtration level <30 ml/minute osteoporosis. There is no association between blood pTH blood, calcium full blood, blood phosphorus and osteoporosis in the research group. A group of patients with pigmented blood <120g/l is 1.3 times higher than osteoporosis than a group of patients with pigmentation blood ≥ 120 g/l.

Article Details

References

1. Bikbov B, et al. (2020), “Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017”, The Lancet, 395(10225): p.709-733.
2. Organization W.H. (1998), “Guidelines for preclinical evaluation and clinical trials in osteoporosis”, World Health Organization, Geneva.
3. Fang Y, et al. (2014), “Early chronic kidney disease–mineral bone disorder stimulates vascular calcification”, Kidney International, 85(1):p. 142-150.
4. Nguyễn Minh Thủy (2010), “Nghiên cứu mật độ xương ở bệnh nhân suy thận mạn từ 50 tuổi trở lên và một số yếu tố liên quan”, Luận văn thạc sĩ Y học, Trường Đại học Y Hà Nội, Hà Nội.
5. Nguyễn Văn Thanh (2009), “Nghiên cứu mật độ xương và một số yếu tố liên quan ở bệnh nhân suy thận mạn chưa điều trị thay thế”, Luận văn tốt nghiệp bác sĩ nội trú, Đại học Y Hà Nội, Hà Nội.
6. Lima-Posada I, et al. (2017), “Gender differences in the acute kidney injury to chronic kidney disease transition”, Scientific Reports, 7(1): p. 12270.
7. Hung L.-W, et al. (2017), “The influence of renal dialysis and hip fracture sites on the 10-year mortality of elderly hip fracture patients: a nationwide population-based observational study”, Medicine, 96(37): p. e7618.
8. Inker L.A, et al. (2014), “KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD”, American Journal of Kidney Diseases, 63(5): p. 713-735.